Anticoagulation management in patients with mechanical heart valves having pacemaker or defibrillator insertion

Thrombosis Research

Volumn 131, Issue 4, 2013, Pages 300-303

  Schulman, S ^a,b,d   Schoenberg, J ^b   Divakara Menon, S ^b   Spyropoulos, A C ^a,b   Healey, J S ^c   Eikelboom, J W ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Anticoagulation; Aortic; Defibrillator; Mechanical heart valve; Mitral; Pacemaker

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

AGED; ANTICOAGULATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; CEREBROVASCULAR ACCIDENT; ELECTIVE SURGERY; FEMALE; HEART VALVE PROSTHESIS; HEMATOMA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MALE; PRIORITY JOURNAL; THROMBOEMBOLISM; TREATMENT OUTCOME;

AGED; ANTICOAGULANTS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEMORRHAGE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84875726611     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.01.012     Document Type: Article

References (24)

1. J.D. Douketis, A.C. Spyropoulos, F.A. Spencer, M. Mayr, A.K. Jaffer, and M.H. Eckman Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e326S e350S
2. D. Hering, C. Piper, R. Bergemann, C. Hillenbach, M. Dahm, and C. Huth Thromboembolic and bleeding complications following St. Jude medical valve replacement Results of the German experience with low-intensity anticoagulation study. Chest 127 2005 53 59
3. M. Robinson, J.S. Healey, J. Eikelboom, S. Schulman, C.A. Morillo, and G.M. Nair Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators Pacing Clin Electrophysiol 32 2009 378 382
4. M.R. Reynolds, D.J. Cohen, A.D. Kugelmass, P.P. Brown, E.R. Becker, and S.D. Culler The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators J Am Coll Cardiol 47 2006 2493 2497
5. P.R. Daniels, R.D. McBane, S.C. Litin, S.A. Ward, D.O. Hodge, and N.F. Dowling Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients Thromb Res 124 2009 300 305
6. M. Cheng, W. Hua, K. Chen, J. Pu, X. Ren, and X. Zhao Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation Europace 11 2009 1183 1187
7. G.F. Michaud, F. Pelosi Jr., M.D. Noble, B.P. Knight, F. Morady, and S.A. Strickberger A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation J Am Coll Cardiol 35 2000 1915 1918
8. D.J. Milic, Z.D. Perisic, S.S. Zivic, Z.A. Stanojkovic, A.M. Stojkovic, and N.D. Karanovic Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment Europace 7 2005 374 379
9. A. Tischenko, L.J. Gula, R. Yee, G.J. Klein, A.C. Skanes, and A.D. Krahn Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin Am Heart J 158 2009 252 256
10. O. Cano, B. Munoz, D. Tejada, J. Osca, M.J. Sancho-Tello, and J. Olague Evaluation of a new standardized protocol for the perioperative management of chronically anticoagulated patients receiving implantable cardiac arrhythmia devices Heart Rhythm 9 2012 361 367
11. C. Tompkins, A. Cheng, D. Dalal, J.A. Brinker, C.T. Leng, and J.E. Marine Dual antiplatelet therapy and heparin «bridging» significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation J Am Coll Cardiol 55 2010 2376 2382
12. J.M. Tolosana, P. Berne, L. Mont, M. Heras, A. Berruezo, and J. Monteagudo Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial Eur Heart J 30 2009 1880 1884
13. U.K. Wiegand, D. LeJeune, F. Boguschewski, H. Bonnemeier, F. Eberhardt, and H. Schunkert Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy Chest 126 2004 1177 1186
14. A. Cheng, S. Nazarian, J.A. Brinker, C. Tompkins, D.D. Spragg, and C.T. Leng Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial Heart Rhythm 8 2011 536 540
15. I. Ahmed, E. Gertner, W.B. Nelson, C.M. House, R. Dahiya, and C.P. Anderson Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation Heart Rhythm 7 2010 745 749
16. C. Marquie, G. De Geeter, D. Klug, C. Kouakam, F. Brigadeau, and O. Jabourek Post-operative use of heparin increases morbidity of pacemaker implantation Europace 8 2006 283 287
17. C. Hammerstingl, and H. Omran Perioperative bridging of chronic oral anticoagulation in patients undergoing pacemaker implantation-a study in 200 patients Europace 13 2011 1304 1310
18. V. Pengo, U. Cucchini, G. Denas, N. Erba, G. Guazzaloca, and L. La Rosa Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study Circulation 119 2009 2920 2927
19. A.S. al-Khadra Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients Pacing Clin Electrophysiol 26 2003 511 514
20. R.A. Denman, D.L. Walters, N. Twidale, and M.L. Masterson The implantation of permanent pacemakers and automatic implantable cardiac defibrillators in patients on warfarin CSANZ 47 Annual Scientific Meeting 1999 [ www.csanz.edu.au/abstracts/47abstracts/041.doc.htm.]
21. M.C. Giudici, S.S. Barold, D.L. Paul, and P. Bontu Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy Pacing Clin Electrophysiol 27 2004 358 360
22. D.J. Goldstein, W. Losquadro, and H.M. Spotnitz Outpatient pacemaker procedures in orally anticoagulated patients Pacing Clin Electrophysiol 21 1998 1730 1734
23. A.C. Spyropoulos, J.D. Douketis, G. Gerotziafas, S. Kaatz, T.L. Ortel, and S. Schulman Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy J Thromb Haemost 10 2012 692 694
24. D. Siegal, J. Yudin, S. Kaatz, J.D. Douketis, W. Lim, and A.C. Spyropoulos Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates Circulation 126 2012 1630 1639